Healthcare Realty Trust Incorporated (NYSE:HR – Get Free Report) declared a quarterly dividend on Tuesday, October 29th, NASDAQ reports. Shareholders of record on Tuesday, November 12th will be given a dividend of 0.31 per share by the real estate investment trust on Wednesday, November 27th. This represents a $1.24 annualized dividend and a yield of 7.03%. The ex-dividend date of this dividend is Tuesday, November 12th.
Healthcare Realty Trust has raised its dividend payment by an average of 33.3% per year over the last three years. Healthcare Realty Trust has a payout ratio of -302.4% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect Healthcare Realty Trust to earn $1.62 per share next year, which means the company should continue to be able to cover its $1.24 annual dividend with an expected future payout ratio of 76.5%.
Healthcare Realty Trust Trading Down 2.8 %
Shares of Healthcare Realty Trust stock traded down $0.51 during trading hours on Wednesday, reaching $17.63. 5,088,076 shares of the company’s stock were exchanged, compared to its average volume of 3,453,706. Healthcare Realty Trust has a 52-week low of $12.77 and a 52-week high of $18.90. The company has a fifty day moving average of $17.90 and a 200-day moving average of $16.88. The firm has a market capitalization of $6.67 billion, a price-to-earnings ratio of -13.26 and a beta of 0.91.
Insider Buying and Selling at Healthcare Realty Trust
In related news, Director Thomas N. Bohjalian purchased 9,000 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The shares were purchased at an average cost of $17.39 per share, with a total value of $156,510.00. Following the completion of the acquisition, the director now directly owns 22,252 shares of the company’s stock, valued at approximately $386,962.28. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director John Knox Singleton purchased 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The stock was acquired at an average cost of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the purchase, the director now owns 57,082 shares of the company’s stock, valued at approximately $1,041,175.68. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas N. Bohjalian acquired 9,000 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was purchased at an average cost of $17.39 per share, with a total value of $156,510.00. Following the completion of the acquisition, the director now owns 22,252 shares of the company’s stock, valued at $386,962.28. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 15,728 shares of company stock valued at $279,069 in the last three months. Corporate insiders own 0.56% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have commented on HR shares. Wells Fargo & Company restated an “underweight” rating and set a $17.00 price objective (up previously from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Scotiabank boosted their target price on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research report on Wednesday, August 7th. Finally, Wedbush raised their price target on shares of Healthcare Realty Trust from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, August 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $17.17.
Check Out Our Latest Stock Report on HR
About Healthcare Realty Trust
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
Read More
- Five stocks we like better than Healthcare Realty Trust
- Want to Profit on the Downtrend? Downtrends, Explained.
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Best Stocks Under $10.00
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What Are Dividend Contenders? Investing in Dividend Contenders
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.